**Hydreight Technologies Reports Robust Q1 2025 Results, Signaling Strategic Success and Growth Trajectory**
VANCOUVER, British Columbia and LAS VEGAS – May 30, 2025 – Hydreight Technologies Inc., a rapidly expanding mobile clinical network and medical platform that delivers at-home medical services across the United States, today announced its financial results for the first quarter ended March 31, 2025. The company showcased strong growth, driven by its strategic initiatives and the increasing demand for its services. All figures are presented in Canadian dollars unless otherwise noted.
**Q1 2025: A Snapshot of Success**
* **Topline Revenue Surge:** Hydreight reported topline revenue of $6.53 million, a significant 34% year-over-year increase, demonstrating the effectiveness of its market approach.
* **Revenue Growth:** GAAP Revenue reached $4.54 million, a notable rise from $3.38 million in Q1 2024.
* **Gross Margin Improvement:** A gross margin of $1.50 million, up from $1.23 million in the same period last year, reflects enhanced operational efficiency.
* **Operational Improvement:** Adjusted EBITDA reached $163,000, showcasing continuous gains in operational performance.
* **Net Profitability:** GAAP Net Income reached $21,000, from a GAAP Net Loss of $309,000 in Q1 2024.
* **Capital Position:** The company closed the quarter with a solid $6.04 million in cash on hand.
* **Strategic Funding:** A $5.4 million gross ($4.8 million net) strategic financing round completed in February is set to fuel Hydreight’s growth initiatives.
* **Key Operational Metrics:** The number of new nurse signups increased about 65% compared to Q1 2024, accompanied by about 48% growth in pharmacy orders, pointing to a robust expansion of its service network.
* **VSDHOne Launch:** The launch of the Personalized Genetic Testing and Wellness Solution on the VSDHOne Platform.
“It was an outstanding quarter,” noted Shane Madden, CEO of Hydreight. “We exceeded our Q1 projections with approximately 34% YOY growth from our first two verticals, a clear sign that our strategy is working. We also secured new customers for VSDHOne, positioning us well to achieve our year-end goals. These accounts are currently onboarding and migrating their new and existing orders to the VSDHOne platform. We’re continuing to increase our investments in the first half of 2025 to support this growth and drive sustainable margin improvements.”
**Financial Performance Highlights:**
(See table below for a summarized view)
| | **Three months ended
March 31,** | | | | | | **% change** |
| :———————————————————– | :——————————: | :——————-: | :———————-: | :———————-: | :———————-: | :———————–: | :———–: |
| | **2025** | | | | | | |
| | | | | | | | |
| Adjusted Revenue | $6,527,957 | | | $4,867,004 | | | 34 % |
| Deduct – deferred business partner contract revenue | $454,140 | | | $(116,978 | | | |
| Deduct – business partner payouts on app service gross revenue | 1,533,695 | | | 1,606,376 | | | |
| GAAP Revenue | $4,540,122 | | | $3,377,606 | | 34% | % |
| | | | | | | | |
| Adjusted Gross Margin | $1,958,605 | | | $1,114,356 | | 76% | % |
| Deduct – deferred business partner contract revenue | 454,140 | | | $(116,978) | | | |
| GAAP Gross Margin | $1,504,465 | | | $1,231,334 | | 22% | % |
| | | | | | | | |
| Adjusted EBITDA | $163,412 | | | $(45,873) | | 456% | % |
| Deduct – amortization and depreciation | 101,004 | | | 46,553 | | | |
| Deduct – share-based payments | 41,505 | | | 216,295 | | | |
| GAAP Net Income (Loss) | $20,903 | | | $(308,721) | | 107% | % |
**Strategic Vision and Forward Outlook**
Hydreight’s leadership emphasized the company’s commitment to responsible scalability, margin improvement, and market share gains in the rapidly growing digital health sector. Key priorities for the remainder of 2025 include:
* Concentrating on growth and projections across three main business areas.
* Reaching profitability and sustaining a positive Adjusted EBITDA.
* Broadening offerings in the fields of genetic testing, anti-aging, and mental wellness.
* Driving the onboarding of high-volume franchise and direct-to-consumer partners.
* Pursuing strategic M&A prospects and investments that amplify revenue and margins.
Hydreight’s strong performance, expansion of services, and strategic outlook clearly signal a company poised for further growth and success in the dynamic landscape of digital healthcare.
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/1363.html
